M&T Bank
ORIC icon

M&T Bank’s Oric Pharmaceuticals ORIC Stock Holding History

M&T Bank’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-99,234
Closed -$801K – 1635
2024
Q4 		$801K Buy
99,234
+14,097
+17% +$129K ﹤0.01% 977
2024
Q3 		$873K Buy
85,137
+13,711
+19% +$136K ﹤0.01% 945
2024
Q2 		$505K Buy
71,426
+21
+0% +$188 ﹤0.01% 1120
2024
Q1 		$982K Sell
71,405
-12,521
-15% -$149K ﹤0.01% 885
2023
Q4 		$772K Buy
83,926
+12,962
+18% +$93.7K ﹤0.01% 966
2023
Q3 		$429K Buy
70,964
+104
+0.1% +$852 ﹤0.01% 1147
2023
Q2 		$550K Buy
+70,860
New +$402K ﹤0.01% 1083
2022
Q1 		– Sell
-20,536
Closed -$302K – 1619
2021
Q4 		$302K Buy
20,536
+5,901
+40% +$92K ﹤0.01% 1247
2021
Q3 		$306K Buy
+14,635
New +$297K ﹤0.01% 1224
2021
Q2 		– Sell
-9,153
Closed -$224K – 1615
2021
Q1 		$224K Hold
9,153
– – ﹤0.01% 1365
2020
Q4 		$310K Buy
9,153
+1,106
+14% +$31.7K ﹤0.01% 1319
2020
Q3 		$201K Buy
8,047
+1,782
+28% +$42.4K ﹤0.01% 1422
2020
Q2 		$211K Buy
+6,265
New +$200K ﹤0.01% 1358

Other funds holding ORIC

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

M&T Bank's ORIC Position: Q1 2025 in Review

M&T Bank sold out of Oric Pharmaceuticals (ORIC) in Q1 2025, closing a stake of 99,234 shares — an estimated $801K sold.

M&T Bank first reported a position in ORIC in Q2 2020 and held it in 13 quarters. The position peaked at $982K in Q1 2024. 143 funds tracked by Wall St. Rank hold ORIC as of Q1 2025.

  • M&T Bank reported no remaining Oric Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 99,234 Oric Pharmaceuticals shares in Q1 2025, an estimated $801K.
  • M&T Bank first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 13 quarters.
  • M&T Bank's Oric Pharmaceuticals position peaked at $982K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.